Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
- Status
- RECRUITING
- Phase
- PHASE3
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Status
- RECRUITING
- Phase
- PHASE1
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Exosome as the Prognostic and Predictive Biomarker in EBC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
- Status
- RECRUITING
- Phase
- PHASE3
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
- Status
- RECRUITING
- Phase
- N/A
Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Biomarker Screening Protocol for Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
PRE-I-SPY Phase I/Ib Oncology Platform Program
- Status
- RECRUITING
- Phase
- PHASE1
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy of Interleukin-2 in Triple Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2